Regardless of obtaining an entire reaction with optimal induction therapy, negligible residual ailment generally persists, necessitating consolidation therapy to mitigate the risk of relapse by eliminating residual sickness. In patients that have obtained 7+three induction therapy, consolidation therapy is initiated with large-dose cytarabine, gen